These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12185828)

  • 1. Simple intravenous antimicrobial desensitization method for pediatric patients.
    De Maria C; Lebel D; Desroches A; Gauvin F
    Am J Health Syst Pharm; 2002 Aug; 59(16):1532-6. PubMed ID: 12185828
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization to antibiotics in children.
    Cernadas JR
    Pediatr Allergy Immunol; 2013 Feb; 24(1):3-9. PubMed ID: 22963144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful meropenem desensitization in a patient with cystic fibrosis.
    Wilson DL; Owens RC; Zuckerman JB
    Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization to inhaled aztreonam lysine in an allergic patient with cystic fibrosis using a novel approach.
    Guglani L; Abdulhamid I; Ditouras J; Montejo J
    Ann Pharmacother; 2012 Oct; 46(10):e25. PubMed ID: 23012384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Tolerability of meropenem in patients with penicillin allergy.
    Ann Intern Med; 2007 Feb; 146(4):I53. PubMed ID: 17310046
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins.
    Atanasković-Marković M; Gaeta F; Medjo B; Viola M; Nestorović B; Romano A
    Allergy; 2008 Feb; 63(2):237-40. PubMed ID: 18186815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity.
    Kwong JC; Urbancic K; Trubiano JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous desensitization to ceftazidime in cystic fibrosis patients.
    Ghosal S; Taylor CJ
    J Antimicrob Chemother; 1997 Apr; 39(4):556-7. PubMed ID: 9145836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Desensitization to antibiotics].
    Moreno Gardea HL; Trevizo de Moreno L
    Rev Alerg Mex; 1997; 44(1):8-12. PubMed ID: 9221103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
    Lucasti C; Popescu I; Ramesh MK; Lipka J; Sable C
    J Antimicrob Chemother; 2013 May; 68(5):1183-92. PubMed ID: 23391714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Hypersensitivity and Desensitizations.
    Castells MC
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):xvii-xviii. PubMed ID: 28965644
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.
    Whitaker P; Etherington C; Williams K; Conway S; Peckham D
    J Cyst Fibros; 2012 Jul; 11(4):353. PubMed ID: 22341263
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
    Mazuski JE; Gasink LB; Armstrong J; Broadhurst H; Stone GG; Rank D; Llorens L; Newell P; Pachl J
    Clin Infect Dis; 2016 Jun; 62(11):1380-1389. PubMed ID: 26962078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of delayed-type hypersensitivity to ceftriaxone and meropenem.
    Dias de Castro E; Leblanc A; Sarmento A; Cernadas JR
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):225-7. PubMed ID: 26549341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity between carbapenems: two case reports.
    Noguerado-Mellado B; Pinto Fernández C; Pineda-Pineda R; Martínez Lezcano P; Álvarez-Perea A; De Barrio Fernández M
    J Allergy Clin Immunol Pract; 2014; 2(6):816-7. PubMed ID: 25439383
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
    Moss RB
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):78-88. PubMed ID: 1991925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.